Total Payments
$1,194
2024 Payments
$557.36
Companies
12
Transactions
41
Medicare Patients
8,263
Medicare Billing
$499,342
Payment Breakdown by Category
Food & Beverage$1,194 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,194 | 41 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $431.09 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $183.33 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $182.66 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $142.13 | 10 | $0 (2024) |
| Amgen Inc. | $60.65 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $48.55 | 2 | $0 (2024) |
| ABIOMED | $45.51 | 2 | $0 (2024) |
| Chiesi USA, Inc. | $34.30 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $18.50 | 1 | $0 (2024) |
| Novo Nordisk Inc | $18.50 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $557.36 | 21 | E.R. Squibb & Sons, L.L.C. ($136.95) |
| 2023 | $541.12 | 13 | Boston Scientific Corporation ($379.05) |
| 2022 | $95.68 | 7 | E.R. Squibb & Sons, L.L.C. ($29.03) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/25/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $36.59 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/11/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.31 | General |
| Category: Cardiovascular | ||||||
| 09/30/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Cardiology | ||||||
| 08/09/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $18.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: DIABETES | ||||||
| 06/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.59 | General |
| Category: Cardiovascular | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $98.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $103.05 | General |
| Category: Cardiovascular | ||||||
| 04/08/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Diabetes | ||||||
| 11/20/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Cardiology | ||||||
| 10/28/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,276 | 2,907 | $266,219 | $130,948 |
| 2022 | 25 | 2,815 | 3,515 | $337,775 | $168,762 |
| 2021 | 24 | 2,357 | 2,855 | $616,063 | $154,008 |
| 2020 | 17 | 815 | 938 | $194,536 | $45,623 |
Total Patients
8,263
Total Services
10,215
Medicare Billing
$499,342
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 315 | 524 | $77,552 | $36,635 | 47.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 293 | 302 | $31,408 | $14,779 | 47.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 136 | 228 | $24,168 | $13,940 | 57.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 66 | 68 | $20,060 | $9,013 | 44.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 56 | 97 | $14,744 | $8,972 | 60.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 144 | 144 | $16,560 | $7,960 | 48.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 79 | 79 | $15,800 | $7,765 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 114 | 129 | $12,900 | $5,731 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 62 | $9,176 | $4,573 | 49.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 353 | 559 | $6,708 | $3,210 | 47.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 31 | 33 | $5,313 | $2,708 | 51.0% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2023 | 13 | 14 | $4,760 | $2,400 | 50.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 25 | 25 | $5,050 | $2,395 | 47.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 154 | 154 | $4,928 | $2,359 | 47.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 154 | 154 | $3,388 | $1,576 | 46.5% |
| 75561 | Mri scan of heart before and after contrast | Facility | 2023 | 15 | 15 | $2,760 | $1,431 | 51.8% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 13 | 14 | $2,268 | $1,168 | 51.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 57 | 60 | $2,220 | $1,112 | 50.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Facility | 2023 | 58 | 58 | $2,262 | $1,085 | 48.0% |
| 93660 | Evaluation of heart function using tilt table | Facility | 2023 | 11 | 11 | $1,496 | $772.86 | 51.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 12 | 25 | $1,125 | $577.50 | 51.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 36 | 53 | $636.00 | $328.12 | 51.6% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 13 | 13 | $364.00 | $184.21 | 50.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 72 | 75 | $375.00 | $174.64 | 46.6% |
| 75565 | Mri scan of blood flow of heart | Facility | 2023 | 11 | 11 | $198.00 | $101.09 | 51.1% |
About Dr. Vahid Tavakoli, M.D
Dr. Vahid Tavakoli, M.D is a Cardiovascular Disease healthcare provider based in Lima, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2014. The National Provider Identifier (NPI) number assigned to this provider is 1386063816.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vahid Tavakoli, M.D has received a total of $1,194 in payments from pharmaceutical and medical device companies, with $557.36 received in 2024. These payments were reported across 41 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,194).
As a Medicare-enrolled provider, Tavakoli has provided services to 8,263 Medicare beneficiaries, totaling 10,215 services with total Medicare billing of $499,342. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Lima, OH
- Active Since 04/14/2014
- Last Updated 09/09/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1386063816
Products in Payments
- WATCHMAN Access System (Device) $244.91
- WATCHMAN FLX (Device) $170.73
- CAMZYOS (Drug) $155.86
- LEQVIO (Drug) $146.39
- Repatha (Biological) $60.65
- BRILINTA (Drug) $53.20
- JARDIANCE (Drug) $48.55
- Impella (Device) $45.51
- FARXIGA (Drug) $44.61
- ENTRESTO (Drug) $36.94
- CLEVIPREX (Drug) $34.30
- WAINUA (Drug) $30.49
- ELIQUIS (Drug) $26.80
- Ozempic (Drug) $18.50
- XARELTO (Drug) $18.50
- S-ICD System Magnet (Device) $15.45
- UPTRAVI (Drug) $15.44
- LOKELMA (Drug) $13.83
- WINREVAIR (Biological) $13.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lima
Dr. Pamela Gardner, Do, DO
Cardiovascular Disease — Payments: $24,123
Cardiovascular Disease $24,123
Masroor Abro, M.d, M.D
Cardiovascular Disease — Payments: $14,304
Cardiovascular Disease $14,304
Dr. Paul Anike, Do, DO
Cardiovascular Disease — Payments: $12,788
Cardiovascular Disease $12,788
Dr. Venkat Battula, Md, MD
Cardiovascular Disease — Payments: $11,418
Cardiovascular Disease $11,418
Adel Shaheen, Md, MD
Cardiovascular Disease — Payments: $8,259
Cardiovascular Disease $8,259
Dr. Mehran Arabpour, Do, DO
Cardiovascular Disease — Payments: $7,110
Cardiovascular Disease $7,110